MOMO'S BREAKOUT BOARD

[midtownmurphy]

$SKDI NEWS OUT!!!

Sun Kissed's Hakuna and Endocanna Health Sign Major Synergistic Product Distribution Agreement
September 18 2020 - 08:00AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook






Sun Kissed's Hakuna and Endocanna Health Sign Major Synergistic Product Distribution Agreement


New York, NY -- September 18, 2020 -- InvestorsHub NewsWire -- Sun Kissed Industries Inc. (OTC PINK: SKDI) ("Sun Kissed", "SKDI", or the "Company"), an emerging leader in the development and sale of CBD consumables, digital content management and online ad monetization technology, is pleased to announce Hakuna and Endocanna Health have signed a mutual product distribution agreement.

Endocanna Health has developed a revolutionary consumer cannabinoid DNA test, EndoDNA, which tests an individual's DNA to make selecting and using CBD personalized. The test and report provide users with scientifically-based suggestions for proper dosing, possible side effects, potential for drug-to-drug interactions, and access to CBD product options that are genetically aligned to their DNA through their online product marketplace.

Hakuna will now be an official distributing partner of the EndoDNA test kit to support their customers with access to personalized CBD solutions. Additionally, Endocanna Health will add Hakuna's CBD product line to their online marketplace with relevant genetic matching profiles for each product, based on individual DNA test results.

"This is an amazing opportunity for current and future Hakuna customers. No longer will consumers have to endure the trial and error of figuring out which CBD product is right for them. They will be able to take the EndoDNA test and receive suggestions on which of our products will be most effective for their DNA profile. This agreement further validates Hakuna's brand and product quality while reaching a whole new audience of motivated buyers who need this type of medicine," comments Ilan Freeman, Hakuna CEO commented.

Carl Grant, Sun Kissed President continued, "We would like to congratulate Mr. Freeman and the team at Hakuna, foreseeing a significant increase in sales for both companies as marketing, website traffic and product orders ramp up."

"We are excited about this partnership because it allows greater access to Endo-Aligned products so customers who take an EndoDNA test will be able to obtain their products through Hakuna's marketplace. This is a true end-to-end solution that will effectively benefit the customer" said Len May, CEO Endocanna Health, Inc.

About Endocanna Health™, Inc.:

Endocanna is a biotechnology research company that utilizes a patent-pending process for its cannabinoid DNA variant report, Endo·Decoded™ and product matching algorithm, Endo·Aligned™. EndoDNA™ provides two ways to submit DNA for analysis, either collected through a simple saliva swab or a direct upload of genetic data files from popular DNA testing services like Ancestry, 23andMe, Family TreeDNA, or MyHeritageDNA. Endocanna's HIPAA compliant and secure health and wellness portal, Mydna.live, provides customers with a personalized experience where they can access their Endo·Decoded report and Endo·Aligned formulation suggestions for their specific genotype. In 2019, cannabis producer Heritage Cannabis Holdings (CSE:CANN; OTC:HERTF) acquired a 30 percent stake in Endocanna Health Inc.

Instagram: endo.dna/

Facebook: EndoCannahealth/

Website: https://www.endocannahealth.com/